Most guidelines still treat indeterminate (Rx) surgical margins after nephrectomy for renal cell carcinoma (RCC) as equivalent to negative (R0) margins, but it is not.

Nephrectomy after HIF-2α antagonist therapy is feasible and safe. Renal surgery following or during exposure to a HIF-2α antagonist appears safe and feasible, with perioperative transfusion rates and ...

For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer. Treatment ...

Major complications occur in 7.0% of patients undergoing nephrectomy with a diagnosis of autosomal dominant polycystic kidney disease (ADPKD), according to a study published online Dec. 17 in Urology ...

For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer. Treatment ...

Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether the results ...

Stage 2 clear cell renal cell carcinoma is typically curable, especially when detected early. Surgery remains the cornerstone ...

The widespread use of standard laparoscopic procedures has been constrained by the technical difficulties presented by patients with PKD who have massively enlarged and cystic kidneys.